Registered entities
ASCLEPIX THERAPEUTICS
Reg. No. 832160334United States
Asclepix Therapeutics, Inc.
Reg. No. 83-2160334United States
Innovation
7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 302 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Investor mix
12 investors on record; lead investors include Perceptive Advisors, Xontogeny.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 1 | 8% |
| Accelerator & incubator | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 3 | 25% |